These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3878240)

  • 1. Serum amyloid P component and autoimmune parameters in the assessment of arthritis activity in MRL/lpr/lpr mice.
    Rordorf-Adam C; Serban D; Pataki A; Grüninger M
    Clin Exp Immunol; 1985 Sep; 61(3):509-16. PubMed ID: 3878240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of superantigen-induced proinflammatory cytokine production and inflammatory arthritis in MRL-lpr/lpr mice by a transcriptional inhibitor of TNF-alpha.
    Edwards CK; Zhou T; Zhang J; Baker TJ; De M; Long RE; Borcherding DR; Bowlin TL; Bluethmann H; Mountz JD
    J Immunol; 1996 Aug; 157(4):1758-72. PubMed ID: 8759766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The in vitro and in vivo induction of anti-double-stranded DNA antibodies in normal and autoimmune mice.
    Fish F; Ziff M
    J Immunol; 1982 Jan; 128(1):409-14. PubMed ID: 6976378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum amyloid P component-DNA complexes are decreased in systemic lupus erythematosus. inverse association with anti-dsDNA antibodies.
    Voss A; Nielsen EH; Svehag SE; Junker P
    J Rheumatol; 2008 Apr; 35(4):625-30. PubMed ID: 18278838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel recombinant congenic mouse strain developing arthritis with enthesopathy.
    Mori S; Tanda N; Ito MR; Oishi H; Tsubaki T; Komori H; Zhang MC; Ono M; Nishimura M; Nose M
    Pathol Int; 2008 Jul; 58(7):407-14. PubMed ID: 18577108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenic significance of serum components in the development of autoimmune polyarthritis in MRL/Mp mice bearing the lymphoproliferation gene.
    Itoh J; Nose M; Kyogoku M
    Am J Pathol; 1991 Sep; 139(3):511-21. PubMed ID: 1887861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An epistatic effect of the female specific loci on the development of autoimmune vasculitis and antinuclear autoantibody in murine lupus.
    Zhang MC; Misu N; Furukawa H; Watanabe Y; Terada M; Komori H; Miyazaki T; Nose M; Ono M
    Ann Rheum Dis; 2006 Apr; 65(4):495-500. PubMed ID: 16150787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the role of the lpr gene in the development of immunological abnormalities and lupus nephritis. Analyses in F2 mice.
    Fujiwara M; Kariyone A; Shiraki M
    Clin Exp Immunol; 1985 Jan; 59(1):161-8. PubMed ID: 3918816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clear suppression of Th1 responses but marginal amelioration of autoimmune manifestations by IL-12p40 transgene in MRL-FAS(lprcg)/FAS(lprcg) mice.
    Yasuda T; Yoshimoto T; Tsubura A; Matsuzawa A
    Cell Immunol; 2001 Jun; 210(2):77-86. PubMed ID: 11520074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pathogenesis of spontaneous chronic polyarthritis in MRL mice].
    Hewicker M; Garcés LH; Kromschröder E; Trautwein G
    Z Rheumatol; 1988; 47(4):219-26. PubMed ID: 3188680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of autoimmune MRL/Ipr mice with monoclonal antibody to Thy-1.2: a single injection has sustained effects on lymphoproliferation and renal disease.
    Seaman WE; Wofsy D; Greenspan JS; Ledbetter JA
    J Immunol; 1983 Apr; 130(4):1713-8. PubMed ID: 6187819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary fat influences the expression of autoimmune disease in MRL/lpr/lpr mice.
    Morrow WJ; Homsy J; Swanson CA; Ohashi Y; Estes J; Levy JA
    Immunology; 1986 Nov; 59(3):439-43. PubMed ID: 3491785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo effects of antibodies against a high frequency idiotype of anti-DNA antibodies in MRL mice.
    Teitelbaum D; Rauch J; Stollar BD; Schwartz RS
    J Immunol; 1984 Mar; 132(3):1282-5. PubMed ID: 6607283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus.
    Okazaki H; Hirata D; Kamimura T; Sato H; Iwamoto M; Yoshio T; Masuyama J; Fujimura A; Kobayashi E; Kano S; Minota S
    J Rheumatol; 2002 Apr; 29(4):707-16. PubMed ID: 11950011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection against autoimmune nephritis in MyD88-deficient MRL/lpr mice.
    Sadanaga A; Nakashima H; Akahoshi M; Masutani K; Miyake K; Igawa T; Sugiyama N; Niiro H; Harada M
    Arthritis Rheum; 2007 May; 56(5):1618-28. PubMed ID: 17469144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Host modifier genes affect mouse autoimmunity induced by the lpr gene.
    Wang Y; Nose M; Kamoto T; Nishimura M; Hiai H
    Am J Pathol; 1997 Dec; 151(6):1791-8. PubMed ID: 9403730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of oral administration of malathion on the course of disease in MRL-lpr mice.
    Rodgers KE
    J Autoimmun; 1997 Aug; 10(4):367-73. PubMed ID: 9237800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavior and immune status of MRL mice in the postweaning period.
    Sakić B; Szechtman H; Talangbayan H; Denburg S; Carbotte R; Denburg JA
    Brain Behav Immun; 1994 Mar; 8(1):1-13. PubMed ID: 8003767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-serum amyloid component P antibodies in patients with systemic lupus erythematosus correlate with disease activity.
    Zandman-Goddard G; Blank M; Langevitz P; Slutsky L; Pras M; Levy Y; Shovman O; Witte T; Doria A; Rovensky J; Shoenfeld Y
    Ann Rheum Dis; 2005 Dec; 64(12):1698-702. PubMed ID: 16014675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of lymphoproliferation in MRL-lpr/lpr mice.
    Smathers PA; Santoro TJ; Chused TM; Reeves JP; Steinberg AD
    J Immunol; 1984 Oct; 133(4):1955-61. PubMed ID: 6332142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.